Trials / Completed
CompletedNCT04267055
DISSECT-N Post Market Data Collection Registry
DISSECT-N (Dissection Navion Registry)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.
Detailed description
DISSECT-N is a prospective, observational, global, multi-center, post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Valiant Navion Thoracic Stent Graft System | Placement of the Valiant Navion for endovascular repair of a dissection in the thoracic aorta. |
Timeline
- Start date
- 2020-06-25
- Primary completion
- 2021-06-28
- Completion
- 2024-07-05
- First posted
- 2020-02-12
- Last updated
- 2025-07-03
Locations
22 sites across 10 countries: United States, Denmark, Greece, Italy, Japan, Netherlands, New Zealand, Slovakia, South Korea, Thailand
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04267055. Inclusion in this directory is not an endorsement.